Cologne, Germany

Nina MÖKER

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nina MÖKER. Retrieved from https://idiyas.com/inventor/nina-möker-4zsc9mtx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nina MÖKER: Innovator in Antibody Research

Introduction

Nina MÖKER is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. Her work has implications for various therapeutic applications, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Nina MÖKER holds a patent for "Anti-Betacellulin Antibodies, Fragments Thereof, and Multi-Specific Binding Molecules." This patent represents her innovative approach to targeting specific proteins, which can lead to breakthroughs in treatment methodologies.

Career Highlights

Throughout her career, Nina has worked with notable companies such as Novartis AG and Miltenyi Biotec B.V. Co., KG. Her experience in these organizations has allowed her to refine her skills and contribute to cutting-edge research in the field of biotechnology.

Collaborations

Nina has collaborated with esteemed colleagues, including Andrew Anh Nguyen and Michael Stefanidakis. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Nina MÖKER is a trailblazer in the field of antibody research, with a patent that underscores her innovative spirit. Her work continues to inspire advancements in biotechnology and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…